Sources

4 Total Sources

GLP-1 Studies Flag New Risks as Retatrutide Shows 25% to 30% Weight Loss

GLP-1 Drugs: New Benefits, Risks, Retatrutide Trials

Technology Networks3d ago

Heymsfield, Gilden Editorial: GLP-1 Therapies Show Unanticipated Positive Effects

The Wall Street Journal3d ago

Why Ozempic Doesn't Help Some People Lose Weight - WSJ

SciTechDaily3d ago

Scientists Are Discovering Unexpected Benefits of GLP-1 Drugs